Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment

NCT04779996 is registered in ClinicalTrials.gov with Auxilio Mutuo Cancer Center as lead sponsor.

NCT NCT04779996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04779996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibodies Production After Covid-19 Vaccination Among Patients With Medical History of Cancer and Anti-CD-20 Treatment
Lead sponsor
Auxilio Mutuo Cancer Center
Phase
Observational
Overall status
Unknown status
Start date
February 16, 2021
Completion date
February 28, 2022
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, covid19, hiv infections